Sara L Marshall1, Deborah V Edidin2, Vincent C Arena3, Dorothy J Becker4, Clareann H Bunker1, Crispin Gishoma5, Francois Gishoma5, Ronald E LaPorte1, Vedaste Kaberuka5, Graham Ogle6, Laurien Sibomana1, Trevor J Orchard7. 1. University of Pittsburgh Graduate School of Public Health, Department of Epidemiology, Pittsburgh, PA, USA. 2. Northwestern University, Feinberg School of Medicine, Pediatrics, Chicago, IL, USA. 3. University of Pittsburgh Graduate School of Public Health, Department of Biostatistics, Pittsburgh, PA, USA. 4. University of Pittsburgh School of Medicine, Department of Pediatrics, Pittsburgh, PA, USA. 5. Association Rwandaise des Diabetiques, Kigali, Rwanda. 6. International Diabetes Federation Life for a Child Program and Australian Diabetes Council, Sydney, NSW, Australia. 7. University of Pittsburgh Graduate School of Public Health, Department of Epidemiology, Pittsburgh, PA, USA. Electronic address: tjo@pitt.edu.
Abstract
AIMS: To assess change in glycemic control concurrent with increased clinic visits, HbA1c testing, and education. Rates of complications were also examined. METHODS: A 1-2 year follow-up of 214 members of the Rwanda Life for a Child program (aged <26 years) with a first HbA1c between June 2009 and November 2010 was conducted. Data were analyzed for the entire cohort and by age (<18 years, ≥18 years). Trajectory analysis was performed to identify trends in HbA1c. RESULTS: Mean overall HbA1c decreased significantly from baseline (11.2 ± 2.7%; 99 ± 30 mmol/mol) to one- (10.2 ± 2.6%; 88 ± 28 mmol/mol) and two- (9.8 ± 26%; 84 ± 25 mmol/mol) year follow up visits. The prevalence of microalbuminuria did not significantly change (21.0%, 18.8%, and 19.6%), nor did nephropathy (4.7%, 7.8%, and 5.4%). However, rates of hypertension (31.8%, 44.9%, and 40.3%) were higher than expected. Five HbA1c groups were identified by trajectory analysis, and those with the worst control monitored their glucose significantly fewer times per week. CONCLUSIONS: The establishment of regular care, HbA1c testing, and increased education is associated with significant improvements in glycemic control in youth with type 1 diabetes (T1D) in sub-Saharan Africa, but the high prevalence of hypertension is of concern.
AIMS: To assess change in glycemic control concurrent with increased clinic visits, HbA1c testing, and education. Rates of complications were also examined. METHODS: A 1-2 year follow-up of 214 members of the Rwanda Life for a Child program (aged <26 years) with a first HbA1c between June 2009 and November 2010 was conducted. Data were analyzed for the entire cohort and by age (<18 years, ≥18 years). Trajectory analysis was performed to identify trends in HbA1c. RESULTS: Mean overall HbA1c decreased significantly from baseline (11.2 ± 2.7%; 99 ± 30 mmol/mol) to one- (10.2 ± 2.6%; 88 ± 28 mmol/mol) and two- (9.8 ± 26%; 84 ± 25 mmol/mol) year follow up visits. The prevalence of microalbuminuria did not significantly change (21.0%, 18.8%, and 19.6%), nor did nephropathy (4.7%, 7.8%, and 5.4%). However, rates of hypertension (31.8%, 44.9%, and 40.3%) were higher than expected. Five HbA1c groups were identified by trajectory analysis, and those with the worst control monitored their glucose significantly fewer times per week. CONCLUSIONS: The establishment of regular care, HbA1c testing, and increased education is associated with significant improvements in glycemic control in youth with type 1 diabetes (T1D) in sub-Saharan Africa, but the high prevalence of hypertension is of concern.
Authors: M Schütt; W Kern; U Krause; P Busch; A Dapp; R Grziwotz; I Mayer; J Rosenbauer; C Wagner; A Zimmermann; W Kerner; R W Holl Journal: Exp Clin Endocrinol Diabetes Date: 2006-07 Impact factor: 2.949
Authors: Sara L Marshall; Deborah Edidin; Vineeta Sharma; Graham Ogle; Vincent C Arena; Trevor Orchard Journal: Pediatr Diabetes Date: 2012-12-28 Impact factor: 4.866
Authors: J A D'Antonio; D Ellis; B H Doft; D J Becker; A L Drash; L H Kuller; T J Orchard Journal: Diabetes Care Date: 1989 Nov-Dec Impact factor: 19.112
Authors: B S Olsen; A Sjølie; P Hougaard; J Johannesen; K Borch-Johnsen; K Marinelli; B Thorsteinsson; S Pramming; H B Mortensen Journal: J Diabetes Complications Date: 2000 Nov-Dec Impact factor: 2.852
Authors: David W Windus; Jack H Ladenson; Cindy K Merrins; Melles Seyoum; Debra Windus; Susan Morin; Beyene Tewelde; Curtis A Parvin; Mitchell G Scott; Jason Goldfeder Journal: Clin Chem Date: 2007-11 Impact factor: 8.327
Authors: Rachel G Miller; Trevor J Orchard; Suna Onengut-Gumuscu; Wei-Min Chen; Stephen S Rich; Tina Costacou Journal: Diabet Med Date: 2021-03-02 Impact factor: 4.213
Authors: Isabelle Hota Tadida Meli; Aurel T Tankeu; Mesmin Y Dehayem; David Chelo; Jean Jacques N Noubiap; Eugene Sobngwi Journal: World J Diabetes Date: 2017-02-15
Authors: Delfina Msanga; Karl Reis; Neema Kayange; Respicious Bakalemwa; Benson Kidenya; Duncan Hau; Christopher Mwanansao; Dina Mahamba; Sofia Ottaru; Elizabeth Kwiyolecha; Robert Peck Journal: Ann Glob Health Date: 2020-04-24 Impact factor: 2.462
Authors: Abdul-Hamid Emwas; Raja Roy; Ryan T McKay; Danielle Ryan; Lorraine Brennan; Leonardo Tenori; Claudio Luchinat; Xin Gao; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Christoph Steinbeck; Reza M Salek; David S Wishart Journal: J Proteome Res Date: 2016-01-20 Impact factor: 4.466